Criminal Finances Act 2017 Aimed at Terrorist Financing Affects All Firms With UK Operations
One of the recent examples of efforts to clamp down on terrorist financing and tax evasion comes from the UK, where the Criminal Finances Act 2017 received Royal Assent in April. The Act, expected to take effect this September, is being touted as a powerful new tool in the investigation and prosecution of tax evasion […]
Digital Reporting, Dashboards Help Execute Store-Level Audits in Real Time
Retailers are under increasing pressure from all directions these days. In May, Credit Suisse estimated that a record 8,600 stores will close in 2017 and that 25 percent of U.S. shopping malls will be shuttered by 2020. At the same time, retailers are facing increasingly complex regulations on everything from public health to environmental issues. […]
High Performance Procurement: Getting More Savings to the Bottom Line, Faster
Only a low percentage of chief procurement officers and chief finance officers feel that they have “very effective” sourcing, according to the most recent research we conducted among 400 procurement and finance professionals. Effective sourcing equates to 10 percent or more in savings year over year. Unfortunately, finance executives say only a small fraction of […]
SEC Expands JOBS Act Registration Filing Provisions to All Companies
Good news for companies that are planning or considering an initial public offering (IPO): The confidential IPO review period, created in 2012 to assist emerging growth companies, is now available to any company considering a public offering, regardless of size. The June decision by the U.S. Securities and Exchange Commission (SEC), effective July 10, 2017, […]
Security and Privacy in Financial Services: Q&A Addressing Top Concerns
Global cybersecurity risk has never been higher, especially at financial institutions, which are often targeted for their high-value information. Earlier this year, Protiviti published its 2017 IT Security and Privacy Survey, which found a strong correlation between board engagement and effective information security, along with a general need to improve data classification, policies and vendor […]
Life Sciences, Pharmaceutical and Medical Device Companies Need to Trust Less and Question More to Keep High-Value Data Safe
Life sciences, pharmaceutical and medical device companies possess sensitive, high-value data that cybercriminals, hacktivists, unscrupulous competitors and other malicious actors aim to steal or otherwise expose. Personally identifiable information (PII), such as employee data and information about clinical trial participants, is a prime target for compromise. So, too, is intellectual property (IP), like drug formulas, […]
